Allstate (NYSE:ALL) PT Raised to $207.00 at JPMorgan Chase & Co.

Allstate (NYSE:ALL) had its price target boosted by JPMorgan Chase & Co. from $205.00 to $207.00 in a report released on Thursday morning, Benzinga reports. The brokerage currently has an overweight rating on the insurance provider’s stock.

A number of other research firms have also weighed in on ALL. Wells Fargo & Company lowered their target price on shares of Allstate from $177.00 to $175.00 and set an equal weight rating on the stock in a report on Friday, August 16th. TD Cowen lifted their target price on Allstate from $193.00 to $224.00 and gave the company a buy rating in a research report on Tuesday, September 3rd. Piper Sandler increased their price target on Allstate from $188.00 to $196.00 and gave the company an overweight rating in a research report on Friday, August 16th. Jefferies Financial Group lifted their price objective on shares of Allstate from $217.00 to $231.00 and gave the stock a buy rating in a report on Wednesday, October 9th. Finally, BMO Capital Markets raised their price target on shares of Allstate from $191.00 to $205.00 and gave the company an outperform rating in a research report on Monday, August 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus target price of $199.24.

Allstate Stock Up 1.3 %

ALL stock opened at $188.28 on Thursday. The stock’s 50 day simple moving average is $184.27 and its 200 day simple moving average is $173.07. The company has a market cap of $49.69 billion, a P/E ratio of 41.56, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. Allstate has a fifty-two week low of $113.04 and a fifty-two week high of $193.97.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. The company had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. Allstate’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period last year, the business earned ($4.42) EPS. On average, research analysts expect that Allstate will post 15.19 earnings per share for the current fiscal year.

Allstate Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Investors of record on Friday, August 30th were paid a $0.92 dividend. The ex-dividend date of this dividend was Friday, August 30th. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. Allstate’s dividend payout ratio is 81.24%.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 238,305 shares of company stock worth $43,082,657 over the last 90 days. Corporate insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Allstate

Several hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its position in shares of Allstate by 3.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock valued at $229,545,000 after purchasing an additional 47,038 shares during the last quarter. Hsbc Holdings PLC raised its stake in shares of Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock worth $160,948,000 after acquiring an additional 31,789 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Allstate by 1.0% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 818,489 shares of the insurance provider’s stock worth $130,680,000 after acquiring an additional 8,454 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Allstate by 181.6% in the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after purchasing an additional 464,337 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its position in Allstate by 11.8% in the 1st quarter. Russell Investments Group Ltd. now owns 716,757 shares of the insurance provider’s stock worth $123,574,000 after purchasing an additional 75,698 shares during the period. 76.47% of the stock is currently owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.